Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis.
García-Marín AM, Cancino-Muñoz I, Torres-Puente M, Villamayor LM, Borrás R, Borrás-Máñez M, Bosque M, Camarena JJ, Colomer-Roig E, Colomina J, Escribano I, Esparcia-Rodríguez O, Gil-Brusola A, Gimeno C, Gimeno-Gascón A, Gomila-Sard B, González-Granda D, Gonzalo-Jiménez N, Guna-Serrano MR, López-Hontangas JL, Martín-González C, Moreno-Muñoz R, Navarro D, Navarro M, Orta N, Pérez E, Prat J, Rodríguez JC, Ruiz-García MM, Vanaclocha H; Valencia Region Tuberculosis Working Group; González-Candelas F, Furió V, Comas I. García-Marín AM, et al. Among authors: vanaclocha h. Lancet Microbe. 2024 Jan;5(1):e43-e51. doi: 10.1016/S2666-5247(23)00252-5. Epub 2023 Dec 4. Lancet Microbe. 2024. PMID: 38061383 Free PMC article.
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant.
Camacho J, Giménez E, Albert E, Zulaica J, Álvarez-Rodríguez B, Torres I, Rusu L, Burgos JS, Peiró S, Vanaclocha H, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Comas I, Gonzáles-Candelas F, Geller R, Navarro D; Valencian Vaccine Research Program (ProVaVac) study group. Camacho J, et al. Among authors: vanaclocha h. J Med Virol. 2023 Jan;95(1):e28284. doi: 10.1002/jmv.28284. Epub 2022 Nov 11. J Med Virol. 2023. PMID: 36333837 Free PMC article.
Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naïve individuals in the general population.
Camacho J, Zulaica J, Giménez E, Rusu L, Velandia-Álvarez S, Albert E, Peiró S, Vanaclocha H, Limón R, Geller R, Navarro D; Valencian Vaccine Research Program (ProVaVac) study group. Camacho J, et al. Among authors: vanaclocha h. J Infect. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2022.12.029. Epub 2023 Jan 1. J Infect. 2023. PMID: 36599404 Free PMC article. No abstract available.
Effectiveness of mRNA booster doses in preventing infections and hospitalizations due to SARS-CoV-2 and its dominant variant over time in Valencian healthcare workers, Spain.
Jiménez-Sepúlveda N, Gras-Valentí P, Chico-Sánchez P, Castro-García JM, Ronda-Pérez E, Vanaclocha H, Peiró S, Burgos JS, Ana Berenguer, Navarro D, Sánchez-Payá J; Valencian vaccine research program ProVaVac study group. Jiménez-Sepúlveda N, et al. Among authors: vanaclocha h. Vaccine. 2024 May 16:S0264-410X(24)00557-7. doi: 10.1016/j.vaccine.2024.05.011. Online ahead of print. Vaccine. 2024. PMID: 38760269 Free article.
Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain.
Sánchez-Saez F, Peiró S, Cuenca L, Vanaclocha H, Limón R, Salas D, Burgos JS, Sánchez-Payá J, Meneu R, Díez J, García-Sempere A, Navarro IH, Rodríguez-Bernal C, Sanfélix-Gimeno G, Navarro D; Valencian vaccine research program (ProVaVac) study group. Sánchez-Saez F, et al. Among authors: vanaclocha h. Vaccine. 2022 Sep 29;40(41):5942-5949. doi: 10.1016/j.vaccine.2022.08.028. Epub 2022 Aug 29. Vaccine. 2022. PMID: 36068110 Free PMC article.
The effectiveness of mRNA vaccines to prevent SARS-CoV-2 infection and hospitalisation for COVID-19 according to the time elapsed since their administration in health professionals in the Valencian Autonomous Community (Spain).
Chico-Sánchez P, Gras-Valentí P, Algado-Sellés N, Jiménez-Sepúlveda N, Vanaclocha H, Peiró S, Burgos JS, Berenguer A, Navarro D, Sánchez-Payá J; Valencian vaccine research program (ProVaVac) study group. Chico-Sánchez P, et al. Among authors: vanaclocha h. Prev Med. 2022 Oct;163:107237. doi: 10.1016/j.ypmed.2022.107237. Epub 2022 Aug 31. Prev Med. 2022. PMID: 36057393 Free PMC article.
Population-based sequencing of Mycobacterium tuberculosis reveals how current population dynamics are shaped by past epidemics.
Cancino-Muñoz I, López MG, Torres-Puente M, Villamayor LM, Borrás R, Borrás-Máñez M, Bosque M, Camarena JJ, Colijn C, Colomer-Roig E, Colomina J, Escribano I, Esparcia-Rodríguez O, García-García F, Gil-Brusola A, Gimeno C, Gimeno-Gascón A, Gomila-Sard B, Gónzales-Granda D, Gonzalo-Jiménez N, Guna-Serrano MR, López-Hontangas JL, Martín-González C, Moreno-Muñoz R, Navarro D, Navarro M, Orta N, Pérez E, Prat J, Rodríguez JC, Ruiz-García MM, Vanaclocha H; Valencia Region Tuberculosis Working Group; Comas I. Cancino-Muñoz I, et al. Among authors: vanaclocha h. Elife. 2022 Jul 26;11:e76605. doi: 10.7554/eLife.76605. Elife. 2022. PMID: 35880398 Free PMC article.
SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection.
Torres I, Giménez E, Albert E, Zulaica J, Álvarez-Rodríguez B, Burgos JS, Peiró S, Limón R, Vanaclocha H, Rodado C, Botija P, Sifre A, Tur B, Lozano RA, Orosa I, Vicente-Ruiz M, Carrión RJ, Clari MÁ, Sánchez-Payá J, Díez-Domingo J, Comas I, González-Candelas F, Geller R, Navarro D; Valencian vaccine research program (ProVaVac) study group. Torres I, et al. Among authors: vanaclocha h. J Med Virol. 2022 Sep;94(9):4216-4223. doi: 10.1002/jmv.27867. Epub 2022 May 25. J Med Virol. 2022. PMID: 35585782 Free PMC article.
SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
Torres I, Bellido-Blasco JB, Gimeno C, Burgos JS, Albert E, Moya-Malo R, Gascó-Laborda JC, Tornero A, Soriano J, Meseguer-Ferrer N, Martínez-Serrano M, Ortíz-Rambla J, Buj H, Hernández N, Peiró S, Salas D, Limón R, Vanaclocha H, Sánchez-Payá J, Díez-Domingo J, Comas I, González-Candelas F, Navarro D; Valencian vaccine research program (ProVaVac) study group. Torres I, et al. Among authors: vanaclocha h. J Med Virol. 2022 Aug;94(8):3776-3782. doi: 10.1002/jmv.27799. Epub 2022 Apr 27. J Med Virol. 2022. PMID: 35445415 Free PMC article.
40 results